keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
C11-BODIPY581/591 is a fluorescent ratio-probe of lipid oxidation . C11-BODIPY581/591 is often used for indexing lipid peroxidation and antioxidant efficacy in model membrane systems and living cells. C11-BODIPY581/591 is applied in the quantitation of ferroptosis.
产品描述 | C11-BODIPY581/591 is a fluorescent ratio-probe of lipid oxidation . C11-BODIPY581/591 is often used for indexing lipid peroxidation and antioxidant efficacy in model membrane systems and living cells. C11-BODIPY581/591 is applied in the quantitation of ferroptosis. |
体外活性 | C11-BODIPY581/591 can easily enter membranes and exhibits good spectral separation of the nonoxidized (595 nm) and oxidized (520 nm) forms[1].Stock solutions of C11 BODIPY581/591 are made by dissolving 1 mg in 20 mM organic solvent.Cells are labeled in DMEM or PBS with 1-20 μM C11-BODIPY581/591 at 37°C, 30 min before the experiment.Alternatively, cells are incubated in DMEM with 1-10 μM preoxidized C11-BODIPY581/591. |
别名 | BODIPY 581/591 C11 |
分子量 | 504.43 |
分子式 | C30H35BF2N2O2 |
CAS No. | 217075-36-0 |
keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BODIPY 581/591 C11 217075-36-0 BODIPY 581/591 C-11 Inhibitor inhibitor inhibit